Concepedia

Hydrochlorothiazide ameliorates polyuria caused by tolvaptan treatment of polycystic kidney disease in PCK rats

Anyi Wang, Takuo Hirose, Yusuke Ohsaki, Chika Takahashi, Emiko Sato, Ikuko Oba‐Yabana, Satoshi Kinugasa, Yoshikazu Muroya, Sadayoshi Ito, Takefumi Mori

Clinical and Experimental Nephrology · 2018 · 20 citations · 34 references

DOI

Concepts

References

34

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

Vicente E. Torres, Arlene B. Chapman, Olivier Devuyst et al. · New England Journal of Medicine · 2012 · 1.6K citations · Full text

, , +14

Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist

Vincent H. Gattone, Xiaofang Wang, Peter C. Harris et al. · Nature Medicine · 2003 · 669 citations

, , +8

Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Arlene B. Chapman, Olivier Devuyst, Kai‐Uwe Eckardt et al. · Kidney International · 2015 · 605 citations · Full text

, , +15

Nitric oxide synthase in macula densa regulates glomerular capillary pressure.

Christopher S. Wilcox, William J. Welch, Faris Murad et al. · Proceedings of the National Academy of Sciences · 1992 · 529 citations

, , +15

US Renal Data System 2012 Annual Data Report

Allan J. Collins, Robert N. Foley, Charles A. Herzog et al. · American Journal of Kidney Diseases · 2012 · 423 citations

, , +12